Front-line immunosuppressive treatment of acquired aplastic anemia. - Wikidata - awgldk - TriplyDB

Front-line immunosuppressive treatment of acquired aplastic anemia.

Front-line immunosuppressive treatment of acquired aplastic anemia.

http://www.wikidata.org/entity/Q38061040

about

Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution.Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the Eur Acquired aplastic anemia in children.Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review.Long-term follow-up study of porcine anti-human thymocyte immunoglobulin therapy combined with cyclosporine for severe aplastic anemia.Expression of CXCR4 on T-cell subsets and Plasma IL-17 Concentrations in Patients with Aplastic Anaemia.Outcomes of immunosuppressant therapy with lower dose of antithymocyte globulin and cyclosporine in aplastic anemia.Outcome of aplastic anaemia in children. A study by the severe aplastic anaemia and paediatric disease working parties of the European group blood and bone marrow transplant.Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in Germany.

P2860

Q34431435-1A4104E2-B75D-4BCE-95D9-CDBCA1BA3D08 Q35571068-7FB43D5D-5660-4EE2-8B34-A41DF9453CDB Q37273222-00215AC4-76B9-45EF-BC00-34F47C4FBAF3 Q37490754-7C58DC8F-92EC-4A1A-A820-35D9E729EA0C Q39269167-DAF642B4-F683-4EC2-A424-673198B9A285 Q40916549-83BE7AD7-B288-4F83-BCBD-034ECCA6473E Q41489911-6D67057E-F999-45D0-B9D6-0D6AAA21F60A Q43554766-3A0DB9D6-812E-4C1C-A43E-F4D7D116A7F0 Q44385094-0739A78D-9286-4DB9-89EB-B268034C0BF3 Q45068889-D265814D-5941-4C31-A93B-98EE25E2FA93

P2860

Front-line immunosuppressive treatment of acquired aplastic anemia.

http://www.wikidata.org/entity/Q38061040

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Front-line immunosuppressive treatment of acquired aplastic anemia.

@en

type

label

Front-line immunosuppressive treatment of acquired aplastic anemia.

@en

prefLabel

Front-line immunosuppressive treatment of acquired aplastic anemia.

@en

P1433

Q38061040-B57CF124-0151-4C02-BC6C-9263EFC85195

P1476

Q38061040-15FADBE2-FEB3-402E-B484-A664DC09C861

P2093

Q38061040-06F269D7-C06D-4DC2-94C7-8B4C9E5DD40A

Q38061040-1D2FC4B6-84E1-4730-8D1D-9D50B5F3644E

Q38061040-76DCBF83-69D7-4DCA-A7D1-39B11ADAD9B8

Q38061040-E3887B24-F55D-478C-826B-B4AA9446FCB1

P2860

Q38061040-1E0BD738-2637-4D7F-BA22-BA704E662F3A

Q38061040-339244C9-BB74-4A86-A87D-E08FDD1483F3

Q38061040-423C2759-89BC-472C-AF12-47B5093141EE

Q38061040-4C8398DC-46C2-4C79-AB46-B940388FDB23

Q38061040-4D5B041A-A715-4246-B353-963051F25428

Q38061040-65010F25-1977-498C-B1C9-D8B75159A5E3

Q38061040-7C36C0EA-E545-4D8F-92A0-D9BDCC024F7D

Q38061040-9CB8FD09-8CB9-4391-8659-EB08F97454BD

Q38061040-A362937D-7916-4ADC-98AD-206CB23C0F9C

Q38061040-A4B2F53C-F864-4239-81A2-4B8928A67EBD

P2888

Q38061040-C70D3B1F-8FE3-4A91-ACAE-6CAEF9AF3047

P304

Q38061040-68D5FC78-CAB1-4E76-94BA-8B1FF28619D1

P31

Q38061040-C933CEF7-300B-47B9-848E-3BE00E6AFC7D

Q38061040-ceab05c9-6ad0-48fd-8450-809049b2a914

P356

Q38061040-46EEB1CA-7A2C-465B-BBC9-F3095FB52F13

P407

Q38061040-973C7CF3-BF69-4E0C-87E4-EF5DE23A0DB4

P433

Q38061040-2223A6A0-A7F0-4246-BFF9-FE31E109A45A

P478

Q38061040-864CD11E-6AB3-42BC-975A-8390E7C9D3BA

P577

Q38061040-63108486-D06D-4996-BCEC-9C3AD8CB9AF6

P5875

Q38061040-83C98F40-3ED8-4E57-A2AA-3C1F2B891216

P6179

Q38061040-F6F35A5B-CD12-41CF-89C5-51B5361574CC

P698

Q38061040-8F1FF6B5-674C-48EE-8CE1-4D8D2C60597A

P356

P1433

Bone Marrow Transplantation

P1476

Front-line immunosuppressive treatment of acquired aplastic anemia.

@en

P2093

A Bacigalupo

http://www.w3.org/2001/XMLSchema#string

C Dufour

http://www.w3.org/2001/XMLSchema#string

J Svahn

http://www.w3.org/2001/XMLSchema#string

Severe Aplastic Anemia–Working Party of the EBMT

http://www.w3.org/2001/XMLSchema#string

P2860

Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells

Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumab

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.

Activity of alemtuzumab monotherapy in treatment-naive, relapsed, and refractory severe acquired aplastic anemia

Eltrombopag and improved hematopoiesis in refractory aplastic anemia.

Horse versus rabbit antithymocyte globulin in acquired aplastic anemia

Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study

Guidelines for the diagnosis and management of aplastic anaemia.

P2888

P304

174-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2012.222

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233724425

http://www.w3.org/2001/XMLSchema#string

P6179

1031407712

http://www.w3.org/2001/XMLSchema#string

P698

23165493

http://www.w3.org/2001/XMLSchema#string